Table 2.
Summary of Clinical Outcomes
| Outcome | New OVT (n=41) | No New OVT (n=118) | p |
|---|---|---|---|
| Treated with anticoagulation*, number (%) | 5 (12.2) | 2 (1.7) | 0.012† |
| Concomitant VTE, number (%) | 3 (7.3) | 4 (3.4) | 0.38† |
| Progression of OVT into IVC or left renal vein, number (%) | 2 (4.9) | NA | NA |
| Cumulative incidence of VTE at 1 year, % | 17.1 | 15.3 | 0.78‡ |
| Overall survival at 1 year (%) | 95.1 | 93.2 | 0.84§ |
Abbreviations: OVT, ovarian vein thrombosis; VTE, venous thromboembolic event
New starts who were not already anticoagulated for VTE before the index CT
Fisher's exact test
Gray's test
Log-rank test